Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case

Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study

Published:2021-06-16 Issue:11 Volume:12 Page:1978-1982
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Sekizaki Tomonori¹^ORCID,Kameda Hiraku¹^ORCID,Nomoto Hiroshi¹^ORCID,Cho Kyu Yong¹²^ORCID,Nakamura Akinobu¹^ORCID,Takahashi Kiyohiko³^ORCID,Miyoshi Arina³^ORCID,Wada Norio³,Takeuchi Jun⁴,Nagai So⁵,Miyoshi Hideaki¹⁶^ORCID,Atsumi Tatsuya¹

Affiliation:

1. Department of Rheumatology, Endocrinology and Nephrology Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

2. Clinical Research and Medical Innovation Center Hokkaido University Hospital Sapporo Japan

3. Department of Diabetes and Endocrinology Sapporo City General Hospital Sapporo Japan

4. Sapporo Diabetes and Thyroid Clinic Sapporo Japan

5. Department of Diabetes and Endocrinology Sapporo Medical Center NTT East Corporation Sapporo Japan

6. Division of Diabetes and Obesity Faculty of Medicine and Graduate School of Medicine Hokkaido University Sapporo Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13578

Reference16 articles.

1. Clinical Use of DPP-4 Inhibitors

2. The structure and function of CD26 in the T-cell immune response

3. Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report

4. Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases

5. Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Hormone and Diabetes Mellitus Interplay: Making Management of Comorbid Disorders Complicated;Hormone and Metabolic Research;2024-08-19

2. Epidemiological, Pathophysiological, and Clinical Considerations on the Interplay between Thyroid Disorders and Type 2 Diabetes Mellitus;Medicina;2023-11-16

3. Association of SGLT-2 Inhibitors with Thyroid Dysfunction: A Drug-Target Mendelian Randomization Study;2023-09-13

4. The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves’ disease;Annals of Medicine;2023-06-23

5. Updates of incretin‐related drugs for the treatment of type 2 diabetes;Journal of Diabetes Investigation;2022-11-14